Navid Ahmadi
Overview
Explore the profile of Navid Ahmadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zdrenka M, Kowalewski A, Ahmadi N, Sadiqi R, Chmura L, Borowczak J, et al.
Biomol Biomed
. 2023 Oct;
24(1):14-29.
PMID: 37877810
Anti-programmed cell death ligand 1 (anti-PD-L1) immunotherapy is an increasingly crucial in cancer treatment. To date, the Federal Drug Administration (FDA) has approved four PD-L1 immunohistochemistry (IHC) staining protocols, commercially...
2.
Ahmadi N, Abbasi M, Torabian A, van Loosdrecht M, Ducoste J
J Hazard Mater
. 2023 Sep;
460:132232.
PMID: 37690201
We investigated the transformation of four pharmaceuticals (Diclofenac, Naproxen, Ibuprofen and Carbamazepine) in a moving bed biofilm reactor subjected to different COD/N ratios in four experimental phases. The shift from...
3.
Ahmadi N, Stone D, Stokan M, Coleman H, Heller G, Smith M, et al.
Indian J Otolaryngol Head Neck Surg
. 2023 Jun;
75(2):661-667.
PMID: 37274960
Introduction: Early laryngeal carcinomas may be treated by transoral laser microsurgery (TLM) or external beam radiotherapy. We review our experience of surgical treatment of laryngeal pre-malignant and malignant lesions over...
4.
Tjahjono R, Ahmadi N, Riffat F, Kudpaje A, Palme C
Indian J Otolaryngol Head Neck Surg
. 2023 Jun;
75(2):278-281.
PMID: 37274959
In certain instances, patients who underwent endoscopic laser excision (ELE) for biopsy-proven early glottic carcinoma do not show any evidence of carcinomatous cells on histopathologic analysis. Our study aims to...
5.
Ahmadi N, Saidov N, Gausterer J, Kramer A, Honeder C, Arnoldner C
Front Vet Sci
. 2023 May;
10:1112857.
PMID: 37124562
Background: Cisplatin is among the most effective antineoplastic agents and has revolutionized the treatment of many cancer diseases. However, one of its serious side effects is a progressive and irreversible...
6.
Ahmadi N, Ahmadi N, Ravindran P, Kim T, Byrne C, Young C
ANZ J Surg
. 2023 Apr;
93(9):2161-2165.
PMID: 37079781
Background: Diverticular disease of the colon occurs commonly in developed countries. Immunosuppressed patients are thought to be more at risk of developing acute diverticulitis, worse disease, and higher complications secondary...
7.
Gausterer J, Schlager M, Ahmadi N, Nieratschker M, Dahm V, Wirth M, et al.
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986834
To shed some light on glycotargeting as a potential strategy for nasal drug delivery, a reliable preparation method for human nasal mucosa samples and a tool to investigate the carbohydrate...
8.
Mahmoudnejad N, Torbati P, Lashay A, Ahmadi N, Guitynavard F
Urol Case Rep
. 2023 Feb;
47:102347.
PMID: 36816609
Primary neuroendocrine tumor (NET) of bladder is rare. It has four subtypes, and large cell neuroendocrine carcinoma (LCNEC) is the rarest. LCNEC affects mostly men over 60. Most common symptom...
9.
Naruka V, McKie M, Ahmadi N, Pama E, S Coonar A, Collaborators M
BMJ Open
. 2022 Sep;
12(9):e058542.
PMID: 36167391
Objectives: To measure the unit-level variation in Acute Kidney Injury (AKI) incidence post-thoracic surgery over a contemporary 1-year period. Secondary aims include examining the associations with sex, age group, operation...
10.
Phung D, Ahmadi N, Gupta R, Clark J, Wykes J, Chng S, et al.
ANZ J Surg
. 2022 Jul;
92(9):2299-2304.
PMID: 35866314
Aim: To present an institution's experience and survival outcomes for patients with head and neck cutaneous squamous cell carcinoma (HNcSCC) and perineural spread (PNS). Method: Retrospective study of patients with...